MetLife Inc. ($MET) Stock Forecast: Down 5.5% Today

What is MetLife Inc.?

MetLife Inc. (MET) is a stable and dividend-paying investment option known for its financial stability and consistent dividends. Despite lacking social media hype, it is considered a valuable choice for risk-aware investors looking for long-term wealth building opportunities.

Why is MetLife Inc. going down?

MET stock is down 5.5% on Feb 6, 2026 14:44

• MetLife Inc. (MET) experienced a bearish movement despite reporting strong Q4 earnings, beating estimates with a 24% year-over-year growth in adjusted operating earnings per share.
• Selling of a significant portion of its stake in MET by Envestnet Asset Management Inc. may have contributed to short-term selling pressure on the stock.
• The market movement could also be influenced by scrutiny on some GAAP and revenue metrics, despite positive analyst sentiment and a healthy dividend yield for MetLife.
• The overall bearish trend in the market, possibly triggered by profit-taking activities and concerns over short-term performance metrics, might have led to the decline in MetLife's stock price today.

MET Price Chart

MET Technical Analysis

MET News

Is MetLife Inc the Safest Flex on Wall Street Right Now? Real Talk on MET

MetLife Inc. (MET) is presented as a stable, dividend-paying investment for long-term wealth building, contrasting with volatile meme stocks and AI growth plays. The article highlights MetLife's defensive sector, global scale, and consistent dividends as key benefits for risk-aware investors. It suggests that while MET lacks social media hype, its financial stability and potential for income make it a valuable consideration for a diversified portfolio.

https://www.ad-hoc-news.de/boerse/news/ueberblick/is-metlife-inc-the-safest-flex-on-wall-street-right-now-real-talk-on-met/68557397

Envestnet Asset Management Inc. Sells 448,986 Shares of MetLife, Inc. $MET

Envestnet Asset Management Inc. significantly reduced its stake in MetLife, Inc. (NYSE:MET) by selling 448,986 shares, leaving it with approximately 0.39% ownership. This comes as MetLife reported an adjusted EPS beat and unveiled a "New Frontier" plan targeting double-digit adjusted EPS growth and substantial free cash flow, while analysts generally hold a "Buy" rating with an average price target of $95.64. Despite positive analyst sentiment and a healthy dividend yield, some GAAP and revenue metrics drew scrutiny, indicating short-term selling pressure.

https://www.marketbeat.com/instant-alerts/filing-envestnet-asset-management-inc-sells-448986-shares-of-metlife-inc-met-2026-02-06/

Prudential Fell 4% on Strategy Pause: Why Analysts Expect $120 in 2026

Prudential Financial (PRU) saw its shares drop 4.1% after an earnings miss and a voluntary 90-day suspension of new sales in its Japan unit due to employee misconduct, impacting 2026 adjusted operating income by $300-$350 million. Despite these headwinds, analysts reiterate Overweight ratings with price targets up to $127, citing the company's strong position in the U.S. retirement market and expanding asset management division. The consensus target price of $120 suggests a 12.1% upside, indicating that the market may be overestimating the impact of the temporary sales pause.

https://www.tikr.com/blog/prudential-fell-4-on-strategy-pause-why-analysts-expect-120-in-2026

Unum Group (NYSE:UNM) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings, Stock Drops

Unum Group (NYSE:UNM) reported Q4 CY2025 earnings with sales of $3.24 billion, missing analyst estimates, and GAAP EPS significantly below expectations at $1.04. The stock subsequently dropped 7.5%. Despite recent acceleration in Book Value Per Share growth, the overall results for the quarter were weaker than anticipated.

https://finviz.com/news/302187/unum-group-nyse-unm-reports-sales-below-analyst-estimates-in-q4-cy2025-earnings-stock-drops

MetLife Q4 Earnings Beat Estimates on Increasing Volumes

MetLife, Inc. reported strong fourth-quarter 2025 adjusted operating earnings per share of $2.58, surpassing Zacks Consensus Estimates by 9.3% and growing 24% year over year. This performance was driven by robust results in its Asia, Group Benefits, RIS, and EMEA segments, benefiting from higher volumes and improved investment income, despite overall revenues lagging consensus. The company also provided a positive outlook for 2026 and reiterated near-term growth targets.

https://www.tradingview.com/news/zacks:6764af412094b:0-metlife-q4-earnings-beat-estimates-on-increasing-volumes/

Trending Today

Teladoc Health Inc. ($TDOC) Stock Forecast: Up 5.6% Today

Tilray Inc. ($TLRY) Stock Forecast: Up 5.8% Today

Intellia Therapeutics, Inc. ($NTLA) Stock Forecast: Up 6.3% Today

SolarEdge Technologies, Inc. ($SEDG) Stock Forecast: Up 7.9% Today

DENTSPLY SIRONA Inc. ($XRAY) Stock Forecast: Down 6.4% Today

FuelCell Energy ($FCEL) Stock Forecast: Up 5.9% Today

Shoals Technologies Group Inc. ($SHLS) Stock Forecast: Down 5.4% Today

Wingstop Inc. ($WING) Stock Forecast: Down 6.8% Today

Delta Air Lines Inc. ($DAL) Stock Forecast: Down 5.1% Today

United Continental Holdings Inc. ($UAL) Stock Forecast: Down 5.3% Today

MetLife Inc. Price History

02.09.2025 - MET Stock was down 2.1%

• Despite MetLife's partnership with Global Citizen to drive social impact, the stock saw a bearish movement, indicating that the market may have been focused on other factors influencing the company.
• Investors might be concerned about the potential costs associated with the three-year initiative with Global Citizen, leading to a sell-off of MET shares.
• The market reaction could also be due to broader economic factors or industry-specific news impacting MetLife's financial performance, overshadowing the positive social impact initiatives.

12.11.2024 - MET Stock was up 5.0%

• MET's positive trend is linked to its collaboration with General Atlantic to introduce Chariot Re and explore opportunities in the reinsurance market.
• This partnership demonstrates MET's proactive strategy to expand its offerings and market presence, which has likely resonated well with investors.
• Diversifying into reinsurance could bring in new revenue sources for MET and strengthen its competitive position in the insurance sector, fostering optimism and a positive market trend for the stock.

31.09.2024 - MET Stock was down 5.3%

• MetLife reported weaker-than-expected Q3 earnings and revenue, missing estimates by -10.65% and 4.66% respectively, leading to a bearish movement in the stock.
• The poor performance was attributed to a weak Group Benefits unit, high costs, and a lower recurring interest margin in RIS, impacting the company's financials negatively.
• Investors may have reacted negatively to the earnings miss, prompting a sell-off in the stock as they reassess the company's growth prospects and financial health moving forward.
• The uncertainty surrounding MetLife's future performance post-Q3 results may have contributed to the bearish sentiment, with investors potentially adopting a cautious approach until clearer signals of improvement emerge.

31.09.2024 - MET Stock was down 7.3%

• MetLife (MET) reported Q3 earnings and revenue below analysts' estimates, leading to a bearish movement in the stock.
• Despite expectations of benefiting from rising premiums and investment income, the actual results fell short, disappointing investors.
• The missed earnings and revenue numbers suggest potential challenges or weaknesses in MetLife's operations during the quarter, raising concerns about its future performance.
• Investors may have reacted negatively to the company's underperformance in key metrics, leading to a sell-off of MetLife's stock.

09.09.2025 - MET Stock was down 1.1%

• MetLife has a history of strong performance, boasting an average annual return of 16.33% over the past 5 years.
• The bearish movement observed today may be linked to profit-taking by investors following a period of sustained growth.
• With a market capitalization of $54.35 billion, MetLife holds a significant position in the financial services sector.
• Today's downward trend could also be a result of broader market factors or industry-specific developments impacting MetLife's stock price.

06.10.2024 - MET Stock was up 6.0%

• Despite missing Q3 earnings and revenue estimates, MetLife (MET) saw a strong bullish movement today.
• The stock's recent decrease in price over the past month may have created an attractive entry point for investors, leading to increased buying pressure.
• The market might be optimistic about MetLife's long-term growth prospects, as evidenced by the stock's 30.00% increase over the past year.
• Investors could be focusing on MetLife's resilience and market positioning amidst challenges in its group benefits unit and high costs, leading to renewed confidence in the company's ability to navigate headwinds and drive future profitability.

03.03.2025 - MET Stock was down 5.1%

• Discussion about MetLife as a top dividend stock might have raised investors' expectations and interest in the company.
• If the company did not meet the high expectations, it could have led to disappointment among investors, resulting in a bearish movement in the stock price.
• Investors might have been expecting stronger dividend performance from MetLife, and any perceived shortcomings in this area could have triggered selling pressure, driving the stock price lower.

07.03.2025 - MET Stock was up 5.1%

• MET's partnership with SKYGEN to revolutionize the dental provider experience is seen as a positive move by investors, indicating a strategic focus on improving customer service and operational efficiency.
• Investors reacted favorably to the announcement, driving the stock price up as they anticipate potential cost savings and enhanced customer satisfaction resulting from the partnership.
• This positive market response reflects investor confidence in MET's capacity to innovate and adjust to evolving market conditions, positioning the company for long-term growth in the insurance sector.

06.01.2025 - MET Stock was down 1.4%

• MetLife (MET) experienced a significant decline in its stock price following the release of its Q4 earnings.
• The company fell short of Q4 earnings expectations by -2.35% but exceeded revenue estimates by 2.65%.
• Investor sentiment turned negative in response to the earnings miss, reflecting apprehensions about MetLife's financial performance.
• The market reacted to the disappointing quarterly results by engaging in a sell-off of MetLife shares.

05.01.2026 - MET Stock was down 0.8%

• Despite surpassing analyst expectations and displaying robust Q4 2025 earnings, MetLife encountered a notable profit decrease during the quarter, potentially influencing the downward trend in its stock price.
• The revenue shortfall in Q4, mainly linked to accounting-based derivative losses, might have sparked investor worries regarding the company's financial stability and operational effectiveness, ultimately fostering adverse market sentiments.
• A decrease in Principal Financial Group Inc.'s ownership stake could have exerted additional selling pressure on MetLife's shares, indicating diminished confidence from a significant institutional investor.
• In summary, the conjunction of profit downturn, revenue discrepancy, and stake reduction likely contributed to the bearish movement in MetLife's stock, overshadowing the positive aspects of its robust earnings and growth prospects.

06.10.2025 - MET Stock was down 3.4%

• Despite strong revenue and earnings growth estimates for Q3, MetLife stock faced bearish movement, suggesting that investors may have had higher expectations.
• Cost pressures potentially impacted the company's profitability, influencing negative market sentiment.
• Investors might have been disappointed by the company's performance in key metrics, as implied by Wall Street projections, contributing to the bearish movement in MET stock today.

06.01.2026 - MET Stock was down 5.5%

• MetLife Inc. (MET) experienced a bearish movement despite reporting strong Q4 earnings, beating estimates with a 24% year-over-year growth in adjusted operating earnings per share.
• Selling of a significant portion of its stake in MET by Envestnet Asset Management Inc. may have contributed to short-term selling pressure on the stock.
• The market movement could also be influenced by scrutiny on some GAAP and revenue metrics, despite positive analyst sentiment and a healthy dividend yield for MetLife.
• The overall bearish trend in the market, possibly triggered by profit-taking activities and concerns over short-term performance metrics, might have led to the decline in MetLife's stock price today.